In addition to its effects on depression-like behavior, intranasal GAL (1–15) also modulated alcohol self-administration, as evaluated using the operant self-administration model—a well-established paradigm for studying motivated drug-seeking behavior. The gene discussed is GAL; the disease is depressive symptom measurement.